Cytokine analysis in a patient with relapsing KikuchiFujimoto disease

Leukemia and Lymphoma

Volumn 53, Issue 4, 2012, Pages 743-745

  Szturz, Petr ^a   Adam, Zdeněk ^a   Chovancová, Jana ^b   Stehlková, Olga ^a   Klabusay, Martin ^a   Feit, Josef ^a   Křen, Leoš ^a   Fojtk, Zdeněk ^a   Krejči, Marta ^a   Pour, Luděk ^a   Hájek, Roman ^a   Mayer, Jiří ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD3 ANTIGEN; CORTICOSTEROID; CYTOKINE; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 5; INTERLEUKIN 7; INTERLEUKIN 8; LACTATE DEHYDROGENASE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; METHYLPREDNISOLONE; MONOCYTE CHEMOTACTIC PROTEIN 1; NONSTEROID ANTIINFLAMMATORY AGENT; PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DIARRHEA; ADULT; BLOOD CELL COUNT; CASE REPORT; ECZEMA; ENZYME BLOOD LEVEL; FEMALE; FEVER; HISTOPATHOLOGY; HUMAN; IMMUNOASSAY; IMMUNOBLAST; KIKUCHI DISEASE; LABORATORY TEST; LETTER; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MYALGIA; PAPULAR RASH; PARAPLEGIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RHEUMATIC DISEASE; SKIN BIOPSY;

ADULT; CYTOKINES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HISTIOCYTIC NECROTIZING LYMPHADENITIS; HUMANS; INFLAMMATION MEDIATORS; LYMPHATIC DISEASES; RECURRENCE;

EID: 84859040735     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.627482     Document Type: Letter

References (15)

1. Kikuchi M. Lymphadenitis showing focal reticulum cell hyperplasia with nuclear debris and phagocytes:a clinicopathological study. Acta Hematol Jpn 1972;35:379-380.
2. Fujimoto Y, Kojima Y, Yamaguchi K. Cervical subacute necrtotizing lymphadenitis. Naika 1972;30:920-927.
3. Park HS, Sung MJ, Park SE, et al. Kikuchi-Fujimoto disease of 16 children in a single center of Korea. Pediatr Allergy Immunol 2007;18:174-178.
4. Kucukardali Y, Solmazgul E, Kunter E, et al. Kikuchi-Fujimoto disease: analysis of 244 cases. Clin Rheumatol 2007;26:50-54.
5. Dorfman RF, Berry GJ. Kikuchi ' s histiocytic necrotizing lymphadenitis: an analysis of 108 cases with emphasis on diff erential diagnosis. Semin Diagn Pathol 1988;5:329-345.
6. Tong TR, Chan OW, Lee KC. Diagnosing Kikuchi disease on fine needle aspiration biopsy: a retrospective study of 44 cases diagnosed by cytology and 8 by histopathology. Acta Cytol 2001; 45:953-957.
7. Yu HL, Lee SS, Tsai HC, et al. Clinical manifestations of Kikuchi' s disease in southern Taiwan. J Microbiol Immunol Infect 2005;38: 35-40.
8. Kubota M, Tsukamoto R, Kurokawa K, et al. Elevated serum interferon gamma and interleukin-(IL-6) in patients with necrotizing lymphadenitis (Kikuchi ' s disease). Br J Haematol 1996;95:613-615.
9. Felgar RE, Furth EE, Wasik MA, et al. Histiocytic necrotizing lymphadenitis (Kikuchi' s disease): in situ end-labeling, immuno histochemical, and serologic evidence supporting cytotoxic lymphocytemediated apoptotic cell death. Mod Pathol 1997;10:231-241.
10. Papanicolaou DA, Wilder RL, Manolagas SC, et al. Th e pathophysiologic roles of interleukin-(IL-6) in human disease. Ann Intern Med 1998;128:127-137.
11. van Roon JA, Jacobs K, Verstappen S, et al. Reduction of serum interleukin (IL-7) levels upon methotrexate therapy in early rheumatoid arthritis correlates with disease suppression. Ann Rheum Dis 2008;67:1054-1055.
12. Lit LC, Wong CK, Tam LS, et al. Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus. Ann Rheum Dis 2006;65: 209-215.
13. Vilá LM, Molina MJ, Mayor AM, et al. Association of serum MIP- 1alpha, MIP-1beta, and RANTES with clinical manifestations, disease activity, and damage accrual in systemic lupus erythematosus. Clin Rheumatol 2007;26:718-722.
14. Kato K, Ohshima K, Anzai K, et al. Elevated serum-soluble Fas ligand in histiocytic necrotizing lymphadenitis. Int J Hematol 2001;73:84-86.
15. Ohshima K, Haraoka S, Takahata Y, et al. Interferon-gamma, interleukin-(IL-18), monokine induced by interferon-gamma and interferon-gamma-inducible protein-10 in histiocytic necrotizing lymphadenitis. Leuk Lymphoma 2002;43:1115-1120.